Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme 1 selected

Guidance programme

Showing 51 to 75 of 881

TitleReference numberPublishedLast updated
Apixaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillationTA275
Apixaban for preventing venous thromboembolism after hip or knee replacement surgeryTA245
Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolismTA341
Apremilast for treating active psoriatic arthritisTA433
Apremilast for treating moderate to severe plaque psoriasisTA419
Aripiprazole for the treatment of schizophrenia in people aged 15 to 17 yearsTA213
Aripiprazole for treating moderate to severe manic episodes in adolescents with bipolar I disorderTA292
Arsenic trioxide for treating acute promyelocytic leukaemiaTA526
Asciminib for treating chronic myeloid leukaemia after 2 or more tyrosine kinase inhibitorsTA813
Atezolizumab for adjuvant treatment of resected non-small-cell lung cancerTA1071
Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after chemotherapyTA520
Atezolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapyTA525
Atezolizumab for untreated advanced or recurrent non-small-cell lung cancer when platinum-doublet chemotherapy is unsuitable (terminated appraisal)TA1047
Atezolizumab for untreated PD-L1-positive advanced urothelial cancer when cisplatin is unsuitableTA739
Atezolizumab in combination for treating metastatic non-squamous non-small-cell lung cancerTA584
Atezolizumab monotherapy for untreated advanced non-small-cell lung cancerTA705
Atezolizumab with bevacizumab for treating advanced or unresectable hepatocellular carcinomaTA666
Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancerTA638
Atezolizumab with carboplatin and nab-paclitaxel for untreated advanced non-squamous non-small-cell lung cancer (terminated appraisal)TA618
Atezolizumab with nab-paclitaxel for untreated PD-L1-positive, locally advanced or metastatic, triple-negative breast cancerTA639
Atogepant for preventing migraineTA973
Autologous chondrocyte implantation for treating symptomatic articular cartilage defects of the kneeTA477
Autologous chondrocyte implantation using chondrosphere for treating symptomatic articular cartilage defects of the kneeTA508
Avacopan for treating severe active granulomatosis with polyangiitis or microscopic polyangiitisTA825
Avalglucosidase alfa for treating Pompe diseaseTA821

Results per page

  1. 10
  2. 25
  3. 50
  4. All